Eiken Chemical Co., Ltd.

TSE:4549 Rapporto sulle azioni

Cap. di mercato: JP¥80.3b

Eiken Chemical Performance dei guadagni passati

Il passato criteri di controllo 1/6

Eiken Chemical's earnings have been declining at an average annual rate of -3.7%, while the Medical Equipment industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 2.6% per year. Eiken Chemical's return on equity is 5%, and it has net margins of 5.9%.

Informazioni chiave

-3.7%

Tasso di crescita degli utili

-3.6%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore7.8%
Tasso di crescita dei ricavi2.6%
Rendimento del capitale proprio5.0%
Margine netto5.9%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Eiken Chemical (TSE:4549) Is Due To Pay A Dividend Of ¥26.00

Aug 21
Eiken Chemical (TSE:4549) Is Due To Pay A Dividend Of ¥26.00

Revenue Miss: Eiken Chemical Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Aug 03
Revenue Miss: Eiken Chemical Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Eiken Chemical (TSE:4549) Will Pay A Dividend Of ¥26.00

Jul 26
Eiken Chemical (TSE:4549) Will Pay A Dividend Of ¥26.00

Eiken Chemical (TSE:4549) Will Pay A Dividend Of ¥26.00

Jul 12
Eiken Chemical (TSE:4549) Will Pay A Dividend Of ¥26.00

Ripartizione dei ricavi e delle spese

Come Eiken Chemical guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

TSE:4549 Ricavi, spese e utili (JPY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 2439,5172,3259,5563,939
30 Jun 2439,7072,3509,6453,939
31 Mar 2440,0522,6349,4063,939
31 Dec 2339,9042,9469,0864,065
30 Sep 2340,6703,0339,7194,065
30 Jun 2342,0384,3379,3644,065
31 Mar 2343,2715,7368,9844,065
31 Dec 2245,0256,5439,9093,408
30 Sep 2244,5206,8739,1073,408
30 Jun 2243,5796,4138,9083,408
31 Mar 2242,9966,2188,7763,408
31 Dec 2141,9515,7969,2543,086
30 Sep 2142,2816,5599,0243,086
30 Jun 2140,9676,2548,8883,086
31 Mar 2138,6675,0448,8283,086
31 Dec 2037,1044,4878,1233,332
30 Sep 2035,3953,3458,1783,332
30 Jun 2035,5673,1718,1823,332
31 Mar 2036,5853,5388,2763,332
31 Dec 1936,7223,5518,4382,904
30 Sep 1937,0363,8228,2642,904
30 Jun 1936,1773,5928,1702,904
31 Mar 1935,7613,4478,1762,904
31 Dec 1835,5223,3038,0783,238
30 Sep 1835,1712,9448,0883,238
30 Jun 1835,0872,7738,0543,238
31 Mar 1834,9912,6087,9823,238
31 Dec 1734,5582,9808,0612,336
30 Sep 1733,9322,8368,0612,336
30 Jun 1733,7402,9647,9532,336
31 Mar 1733,2742,9187,8502,336
31 Dec 1633,1883,0247,7822,272
30 Sep 1632,6702,8827,7162,272
30 Jun 1632,5862,5877,6272,272
31 Mar 1632,1632,4297,5942,272
31 Dec 1531,7272,3897,3302,456
30 Sep 1531,4922,0137,6172,456
30 Jun 1531,1802,1527,6662,456
31 Mar 1531,0142,1007,5852,456
31 Dec 1430,7501,8778,0871,945
30 Sep 1430,7812,2487,6161,945
30 Jun 1430,1351,9867,4931,945
31 Mar 1430,0271,9847,4221,945
31 Dec 1329,3112,5697,4471,840

Guadagni di qualità: 4549 has high quality earnings.

Margine di profitto in crescita: 4549's current net profit margins (5.9%) are lower than last year (7.5%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 4549's earnings have declined by 3.7% per year over the past 5 years.

Accelerare la crescita: 4549's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Guadagni vs Settore: 4549 had negative earnings growth (-23.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.7%).


Rendimento del capitale proprio

ROE elevato: 4549's Return on Equity (5%) is considered low.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate